Literature DB >> 26130785

Role of high sensitivity C-reactive protein and other risk factors in intracranial and extracranial artery occlusion in patients with ischaemic stroke.

Dan Xie1, Li Deng1, Xiao-dong Liu1, Ji-mei Li1, Yong-bo Zhang2.   

Abstract

OBJECTIVE: A retrospective case-control study to identify stroke-associated risk factors and quantify serum C-reactive protein in patients with ischaemic stroke, with or without intracranial and/or extracranial artery occlusion (IEAO).
METHODS: Patients with ischaemic stroke and internal carotid artery occlusion (ICAO), middle cerebral artery occlusion (MCAO), ICAO + MCAO, or no IEAO (control patients) were retrospectively recruited. Data regarding stroke-associated risk factors were retrieved from medical records. High sensitivity (hs)-CRP was quantified within 3 days of hospital admission.
RESULTS: Patients with ICAO (n = 89), MCAO (n = 74) and ICAO + MCAO (n = 29) had significantly higher serum hs-CRP concentrations, and were significantly more likely to have coronary heart disease, a history of stroke, and more than three stroke-associated risk factors than control patients (n = 84).
CONCLUSIONS: Coronary heart disease and a history of stroke are risk factors for ischaemic stroke with IEAO. Hs-CRP may be used as a marker for IEAO.
© The Author(s) 2015.

Entities:  

Keywords:  Ischaemic stroke; high-sensitivity C-reactive protein; internal carotid artery occlusion; middle cerebral artery occlusion; risk factors

Mesh:

Substances:

Year:  2015        PMID: 26130785     DOI: 10.1177/0300060515586246

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  1 in total

1.  GlycA, hsCRP differentially associated with MI, ischemic stroke: In the Dallas Heart Study and Multi-Ethnic Study of Atherosclerosis: GlycA, hsCRP Differentially Associated MI, Stroke.

Authors:  Kayla A Riggs; Parag H Joshi; Amit Khera; James D Otvos; Philip Greenland; Colby R Ayers; Anand Rohatgi
Journal:  Am J Prev Cardiol       Date:  2022-08-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.